Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
A licensed clinician reviews your info and builds a plan tailored to you
Distracting yourself can help, too
Robust direct comparisons of clinical outcomes are lacking
Participants were randomly assigned in a 2:1:1:1:1:2:2 ratio to receive subcutaneous retatrutide (1 mg, 4 mg [initial dose, 2 mg], 4 mg [initial dose, 4 mg], 8 mg [initial dose, 2 mg], 8 mg [initial dose, 4 mg], or 12 mg [initial dose, 2 mg]) or placebo once weekly for 48 weeks
US$ 22.12
US$ 25.72
US$ 21.74
US$ 27.72
US$ 24.74
US$ 20.35
US$ 21.12
US$ 24.06
US$ 28.26
US$ 25.30
US$ 25.69
US$ 20.74
US$ 26.26
US$ 26.92
US$ 23.85
